EUR 3.11
(0.32%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.67 Million EUR | 38.25% |
2022 | 1.21 Million EUR | 52.96% |
2021 | 793 Thousand EUR | 21.09% |
2020 | 654.86 Thousand EUR | 141.33% |
2019 | 271.35 Thousand EUR | 4.76% |
2018 | 259.01 Thousand EUR | 24.59% |
2017 | 207.89 Thousand EUR | 14.9% |
2016 | 180.93 Thousand EUR | 3.71% |
2015 | 174.47 Thousand EUR | -1.22% |
2014 | 176.61 Thousand EUR | -1.92% |
2013 | 180.07 Thousand EUR | -0.09% |
2012 | 180.23 Thousand EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.57 Million EUR | 0.0% |
2024 Q1 | 1.57 Million EUR | -5.96% |
2023 Q3 | 1.67 Million EUR | 6.75% |
2023 FY | 1.67 Million EUR | 38.25% |
2023 Q1 | 1.57 Million EUR | 29.51% |
2023 Q4 | 1.67 Million EUR | 0.0% |
2023 Q2 | 1.57 Million EUR | 0.0% |
2022 Q1 | 936 Thousand EUR | 18.03% |
2022 FY | 1.21 Million EUR | 52.96% |
2022 Q4 | 1.21 Million EUR | 0.0% |
2022 Q3 | 1.21 Million EUR | 29.59% |
2022 Q2 | 936 Thousand EUR | 0.0% |
2021 Q4 | 793 Thousand EUR | 0.0% |
2021 Q1 | 731.33 Thousand EUR | 11.68% |
2021 FY | 793 Thousand EUR | 21.09% |
2021 Q2 | 731.33 Thousand EUR | 0.0% |
2021 Q3 | 793 Thousand EUR | 8.43% |
2020 Q2 | 492.81 Thousand EUR | 0.0% |
2020 Q4 | 654.86 Thousand EUR | -0.02% |
2020 Q1 | 492.81 Thousand EUR | 81.62% |
2020 FY | 654.86 Thousand EUR | 141.33% |
2020 Q3 | 655 Thousand EUR | 32.91% |
2019 FY | 271.35 Thousand EUR | 4.76% |
2019 Q2 | 259.01 Thousand EUR | 0.0% |
2019 Q4 | 271.35 Thousand EUR | 0.0% |
2019 Q3 | 271.35 Thousand EUR | 4.76% |
2019 Q1 | 259.01 Thousand EUR | 0.0% |
2018 Q4 | 259.01 Thousand EUR | 0.0% |
2018 FY | 259.01 Thousand EUR | 24.59% |
2018 Q2 | 211.36 Thousand EUR | 0.0% |
2018 Q1 | 211.36 Thousand EUR | 1.67% |
2018 Q3 | 259.01 Thousand EUR | 22.54% |
2017 FY | 207.89 Thousand EUR | 14.9% |
2017 Q4 | 207.89 Thousand EUR | -1.64% |
2017 Q3 | 211.36 Thousand EUR | 18.55% |
2017 Q2 | 178.3 Thousand EUR | -24.81% |
2017 Q1 | 237.14 Thousand EUR | 31.07% |
2016 Q2 | 169.19 Thousand EUR | 0.0% |
2016 Q1 | 169.19 Thousand EUR | 0.0% |
2016 FY | 180.93 Thousand EUR | 3.71% |
2016 Q4 | 180.93 Thousand EUR | -0.63% |
2016 Q3 | 182.07 Thousand EUR | 7.61% |
2015 FY | 174.47 Thousand EUR | -1.22% |
2014 FY | 176.61 Thousand EUR | -1.92% |
2013 FY | 180.07 Thousand EUR | -0.09% |
2012 FY | 180.23 Thousand EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Biotechnologies Assets SA | -3.15 Million EUR | 153.146% |
Pharma Mar, S.A. | 39.28 Million EUR | 95.732% |
Laboratorios Farmaceuticos Rovi, S.A. | 337.96 Million EUR | 99.504% |